CellCor
MarketedMedia brand for stem cells, T cells, NK cells and exosomes, with plans announced to release four new media in 2026.
FROM PUBLIC EVENTS · 2026-11-15
Global approvals · expansion Widening its overseas customers with a first European supply deal and registration work in Japan.
Roles often seen at this stageManufacturing & MSAT · BD & licensing · Research & development
A maker of chemically defined cell-culture media for cell and gene therapies, widening supply to customers in China, Japan and Europe.
Media brand for stem cells, T cells, NK cells and exosomes, with plans announced to release four new media in 2026.
Entered Europe for the first time with a white-label supply agreement with a German company.
Began preparing local registration of a medium for a stem-cell therapy's commercial use in Japan.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.